Interactive workshops to exchange ideas with experts on clinical development: Copenhagen and Munich
RALEIGH, N.C., April 16 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host two interactive workshops on how to manage the challenges posed by current market conditions, improve planning for successful trials and marketing approvals, and increase efficiency working with different vendors throughout the development process. The first workshop will take place in Munich on April 21, 2009; the second workshop will occur on April 23, 2009 in Copenhagen.
Guest speakers from the biotech sector, special vendors, and analysts will present and discuss the challenges faced by the biotechnology industry in the current environment. Speakers for the event in Munich include: Dr. Michael Kirchengast - VP and Head, Scientific Affairs at PRA; Dr. Ute Berger - VP, Medical Affairs at PRA; Dr. Siegfried Bialojan - Executive Director and Head European Life Science Center at Ernst & Young; Dr. Graham Bunn - VP Global Partnerships & Alliances at Medidata Solutions Worldwide; and Dr. Frank Henke - Head Clinical Operations at BioTie. Speakers for Copenhagen include: Mr. John Richmond - Project Manager, Europe for invivodata, inc.; as well as speakers from the Munich event: Dr. Bialojan from Ernst & Young, and Dr. Berger and Dr. Kirchengast from PRA.
PRA's clinical development services are well suited for the needs of emerging biotechs because we combine a totally flexible service offering which ranges from single services to complete development programs with our globally integrated solutions. Over 50% of PRA's project work is with biotechnology companies - a direct result of our flexible operational model and commitment to excellence.
About PRA International
PRA International is one of the leading global clinical research organizations, conducting clinical trials in more than 65 countries across six continents. PRA provides outsourced clinical services across all phases of pharmaceutical and biotech drug development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.
|SOURCE PRA International|
Copyright©2009 PR Newswire.
All rights reserved